➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Baxter
Harvard Business School
McKesson
Express Scripts

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

MONOPRIL-HCT Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for MONOPRIL-HCT
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 5
Formulation / Manufacturing:see details
DailyMed Link:MONOPRIL-HCT at DailyMed
Drug patent expirations by year for MONOPRIL-HCT
Recent Clinical Trials for MONOPRIL-HCT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of NebraskaPhase 4
Ranbaxy Laboratories LimitedN/A

See all MONOPRIL-HCT clinical trials

Paragraph IV (Patent) Challenges for MONOPRIL-HCT
Tradename Dosage Ingredient NDA Submissiondate
MONOPRIL-HCT TABLET;ORAL fosinopril sodium; hydrochlorothiazide 020286

US Patents and Regulatory Information for MONOPRIL-HCT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb MONOPRIL-HCT fosinopril sodium; hydrochlorothiazide TABLET;ORAL 020286-002 Nov 30, 1994 DISCN Yes No   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb MONOPRIL-HCT fosinopril sodium; hydrochlorothiazide TABLET;ORAL 020286-001 Nov 30, 1994 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MONOPRIL-HCT

Supplementary Protection Certificates for MONOPRIL-HCT

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0053902 SPC/GB96/024 United Kingdom   Start Trial SPC/GB96/024:, EXPIRES: 20061126
0053902 SPC/GB93/028 United Kingdom   Start Trial SPC/GB93/028, EXPIRES: 20050702
0053902 96C0036 Belgium   Start Trial PRODUCT NAME: FAMCICLOVIR; NAT. REGISTRATION NO/DATE: NL 21325 19960708; FIRST REGISTRATION: GB - 10592/0035 19931210
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Medtronic
McKinsey
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.